Novartis
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate.
CEOVasant Narasimhan
CEOVasant Narasimhan
Employees104,323
Employees104,323
HeadquartersBasel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded1996
Founded1996
Employees104,323
Employees104,323
NVS Key Statistics
Market cap215.69B
Market cap215.69B
Price-Earnings ratio9.48
Price-Earnings ratio9.48
Dividend yield2.33
Dividend yield2.33
Average volume2.02M
Average volume2.02M
High today$91.30
High today$91.30
Low today$89.42
Low today$89.42
Open price$90.98
Open price$90.98
Volume2.67M
Volume2.67M
52 Week high$94.26
52 Week high$94.26
52 Week low$74.09
52 Week low$74.09
NVS News
Benzinga 2d
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital OfferingIn this article: Sandoz , a generic pharmaceuticals and biosimilar unit of Novartis AG (NYSE: NVS), has agreed to acquire worldwide product rights for systemic...
Yahoo Finance 3d
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio - Yahoo FinanceSandoz plans to acquire worldwide product rights for Mycamine ® (micafungin sodium) from Astellas Acquiring leading global echinocandin, one of three major ant...
Yahoo Finance 4d
Those who invested in Novartis a year ago are up 15% - Yahoo FinanceThe simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better than average stocks (as part of a divers...
Analyst ratings
56%
of 27 ratingsBuy
33.3%
Hold
55.6%
Sell
11.1%
NVS Earnings
$0.00
$0.57
$1.14
$1.71
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated$1.39 per share
Estimated$1.39 per share
ActualAvailable Feb 1, Pre-Market
ActualAvailable Feb 1, Pre-Market